AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Minoglib-M 5mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Minova Life Sciences Pvt Ltd

Salt Composition

Glibenclamide (5mg) + Metformin (500mg)

Overview Minoglib-M 5mg/500mg Tablet

Glimepiride/Metformin 5mg/500mg tablets are antidiabetic medications combining two agents for adult type 2 diabetes management. This formulation helps regulate blood glucose. Administer this medication with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. This medication complements a comprehensive diabetes management plan, incorporating diet, exercise, and weight management as directed by your doctor. Lifestyle modifications are vital for diabetes control. Hypoglycemia (low blood sugar) is a common side effect; learn to recognize symptoms like sweating, dizziness, headache, and tremors, and carry a fast-acting glucose source. Alcohol increases hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Inform your doctor of any heart conditions before commencing treatment. Pregnant or lactating individuals should consult their physician. Regular blood glucose monitoring is essential, along with potential blood tests to assess blood cell counts and liver function.

Uses of Minoglib-M 5mg/500mg Tablet

Managing Type 2 Diabetes

Major Benefits of Minoglib-M 5mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take the Minoglib-M 5mg/500mg tablet with a meal.

Common Side effects of Minoglib-M 5mg/500mg Tablet:

  • Nausea
  • Vomiting
  • Diarrhea
  • Flatulence

How to use Minoglib-M 5mg/500mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take the Minoglib-M 5mg/500mg Tablet with a meal.

How Minoglib-M 5mg/500mg Tablet works:

Glibenclamide and metformin are combined in the antidiabetic medication Minoglib-M 5mg/500mg tablet.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of alcohol and Minoglib-M 5mg/500mg tablets is contraindicated.

PregnancyPregnancySAFE IF PRESCRIBED

The use of Minoglib-M 5mg/500mg tablets during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no harmful consequences for fetal development; nonetheless, data from human studies are scarce.

Breast feedingBreast feedingCAUTION

The use of Minoglib-M 5mg/500mg tablets necessitates careful consideration during lactation. Mothers should discontinue breastfeeding for the duration of their treatment and until the medication is fully cleared from their system.

DrivingDrivingCONSULT YOUR DOCTOR

The effect of Minoglib-M 5mg/500mg Tablet on driving ability is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.

KidneyKidneyUNSAFE

The use of Minoglib-M 5mg/500mg tablets is likely inadvisable for individuals with impaired kidney function and should be avoided. Medical advice is recommended.

LiverLiverCAUTION

Individuals with liver impairment should use Minoglib-M 5mg/500mg tablets cautiously, potentially requiring dosage modification. Consult a physician before use. A reduced initial dose is typically prescribed for patients experiencing mild to moderate liver disease; the medication is unsuitable for those with severe hepatic dysfunction.

What if you forget to take Minoglib-M 5mg/500mg Tablet :

Should you forget to take a Minoglib-M 5mg/500mg Tablet, administer it immediately upon remembrance. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Minoglib-M 5mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Treatment

FAQs on Minoglib-M 5mg/500mg Tablet

Minoglib-M 5mg/500mg tablets combine glibenclamide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glibenclamide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It is not suitable for type 1 diabetes.
Type 2 diabetes, the most prevalent form of diabetes, arises from the body's inability to produce sufficient insulin or utilize it effectively. This results in elevated blood glucose levels, causing serious health issues. High blood sugar manifests as frequent urination, excessive thirst, and increased hunger. Untreated, type 2 diabetes leads to long-term complications such as nerve damage (neuropathy), kidney damage (nephropathy), eye damage (retinopathy), foot problems, and an increased risk of heart disease.
Minoglib-M 5mg/500mg tablets may cause common side effects including low blood sugar, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Minoglib-M 5mg/500mg tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Prolonged use of Minoglib-M 5mg/500mg tablets can interfere with vitamin B12 absorption, potentially leading to deficiency. This deficiency, if left untreated, may manifest as anemia, neurological symptoms (including tingling, numbness in extremities, weakness, and ataxia), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Minoglib-M 5mg/500mg Tablets are contraindicated in patients with allergies to any ingredient, those with moderate to severe kidney disease, and those with metabolic acidosis, including diabetic ketoacidosis.
Combining Minoglib-M 5mg/500mg tablets with alcohol is unsafe. Alcohol can worsen low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Minoglib-M 5mg/500mg Tabl...
25
MRP 30
16% off